These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 22615645)
21. Quantitative biopharmaceutics classification system: the central role of dose/solubility ratio. Rinaki E; Valsami G; Macheras P Pharm Res; 2003 Dec; 20(12):1917-25. PubMed ID: 14725354 [TBL] [Abstract][Full Text] [Related]
22. Prediction of solubility and permeability class membership: provisional BCS classification of the world's top oral drugs. Dahan A; Miller JM; Amidon GL AAPS J; 2009 Dec; 11(4):740-6. PubMed ID: 19876745 [TBL] [Abstract][Full Text] [Related]
23. Comparison of the permeability of metoprolol and labetalol in rat, mouse, and Caco-2 cells: use as a reference standard for BCS classification. Incecayir T; Tsume Y; Amidon GL Mol Pharm; 2013 Mar; 10(3):958-66. PubMed ID: 23327720 [TBL] [Abstract][Full Text] [Related]
24. Biopharmaceutics classification of selected beta-blockers: solubility and permeability class membership. Yang Y; Faustino PJ; Volpe DA; Ellison CD; Lyon RC; Yu LX Mol Pharm; 2007; 4(4):608-14. PubMed ID: 17637014 [TBL] [Abstract][Full Text] [Related]
25. pH-Dependent solubility and permeability criteria for provisional biopharmaceutics classification (BCS and BDDCS) in early drug discovery. Varma MV; Gardner I; Steyn SJ; Nkansah P; Rotter CJ; Whitney-Pickett C; Zhang H; Di L; Cram M; Fenner KS; El-Kattan AF Mol Pharm; 2012 May; 9(5):1199-212. PubMed ID: 22489626 [TBL] [Abstract][Full Text] [Related]
26. Comparing multilabel classification methods for provisional biopharmaceutics class prediction. Newby D; Freitas AA; Ghafourian T Mol Pharm; 2015 Jan; 12(1):87-102. PubMed ID: 25397721 [TBL] [Abstract][Full Text] [Related]
27. The utility of rat jejunal permeability for biopharmaceutics classification system. Zakeri-Milani P; Valizadeh H; Tajerzadeh H; Islambulchilar Z Drug Dev Ind Pharm; 2009 Dec; 35(12):1496-502. PubMed ID: 19929209 [TBL] [Abstract][Full Text] [Related]
28. In vitro solubility, dissolution and permeability studies combined with semi-mechanistic modeling to investigate the intestinal absorption of desvenlafaxine from an immediate- and extended release formulation. Franek F; Jarlfors A; Larsen F; Holm P; Steffansen B Eur J Pharm Sci; 2015 Sep; 77():303-13. PubMed ID: 26091569 [TBL] [Abstract][Full Text] [Related]
29. Establishment of modified biopharmaceutics classification system absorption model for oral Traditional Chinese Medicine (Sanye Tablet). Li H; Cao X; Liu Y; Liu T; Wang M; Ren X; Dou Z J Ethnopharmacol; 2019 Nov; 244():112148. PubMed ID: 31400507 [TBL] [Abstract][Full Text] [Related]
30. Provisional biopharmaceutical classification of some common herbs used in Western medicine. Waldmann S; Almukainzi M; Bou-Chacra NA; Amidon GL; Lee BJ; Feng J; Kanfer I; Zuo JZ; Wei H; Bolger MB; Löbenberg R Mol Pharm; 2012 Apr; 9(4):815-22. PubMed ID: 22352942 [TBL] [Abstract][Full Text] [Related]
31. The biowaiver extension for BCS class III drugs: the effect of dissolution rate on the bioequivalence of BCS class III immediate-release drugs predicted by computer simulation. Tsume Y; Amidon GL Mol Pharm; 2010 Aug; 7(4):1235-43. PubMed ID: 20557130 [TBL] [Abstract][Full Text] [Related]
32. Intestinal permeability study of minoxidil: assessment of minoxidil as a high permeability reference drug for biopharmaceutics classification. Ozawa M; Tsume Y; Zur M; Dahan A; Amidon GL Mol Pharm; 2015 Jan; 12(1):204-11. PubMed ID: 25423288 [TBL] [Abstract][Full Text] [Related]
33. Advantage of the Dissolution/Permeation System for Estimating Oral Absorption of Drug Candidates in the Drug Discovery Stage. Miyaji Y; Fujii Y; Takeyama S; Kawai Y; Kataoka M; Takahashi M; Yamashita S Mol Pharm; 2016 May; 13(5):1564-74. PubMed ID: 27031624 [TBL] [Abstract][Full Text] [Related]
34. A perspective on the physicochemical and biopharmaceutic properties of marketed antiseizure drugs-From phenobarbital to cenobamate and beyond. Odi R; Bibi D; Wager T; Bialer M Epilepsia; 2020 Aug; 61(8):1543-1552. PubMed ID: 32614073 [TBL] [Abstract][Full Text] [Related]
35. Prediction of bioavailability of selected bisphosphonates using in silico methods towards categorization into a biopharmaceutical classification system. Biernacka J; Betlejewska-Kielak K; Kłosińska-Szmurło E; Pluciński FA; Mazurek AP Acta Pol Pharm; 2013; 70(5):877-82. PubMed ID: 24147367 [TBL] [Abstract][Full Text] [Related]
36. Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach. Winiwarter S; Bonham NM; Ax F; Hallberg A; Lennernäs H; Karlén A J Med Chem; 1998 Dec; 41(25):4939-49. PubMed ID: 9836611 [TBL] [Abstract][Full Text] [Related]
37. Physicochemical determinants of passive membrane permeability: role of solute hydrogen-bonding potential and volume. Goodwin JT; Conradi RA; Ho NF; Burton PS J Med Chem; 2001 Oct; 44(22):3721-9. PubMed ID: 11606137 [TBL] [Abstract][Full Text] [Related]
38. Physicochemical profiling (solubility, permeability and charge state). Avdeef A Curr Top Med Chem; 2001 Sep; 1(4):277-351. PubMed ID: 11899112 [TBL] [Abstract][Full Text] [Related]
39. Logistic Classification Models for pH-Permeability Profile: Predicting Permeability Classes for the Biopharmaceutical Classification System. Oja M; Sild S; Maran U J Chem Inf Model; 2019 May; 59(5):2442-2455. PubMed ID: 30790522 [TBL] [Abstract][Full Text] [Related]
40. Classification of WHO Essential Oral Medicines for Children Applying a Provisional Pediatric Biopharmaceutics Classification System. delMoral-Sanchez JM; Gonzalez-Alvarez I; Gonzalez-Alvarez M; Navarro A; Bermejo M Pharmaceutics; 2019 Oct; 11(11):. PubMed ID: 31683740 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]